6
C. Ao et al. / Tetrahedron: Asymmetry xxx (2016) xxx–xxx
To a solution of (R)-bistriflate (4.57 g, 8.30 mmol) and NiCl2(-
J = 8.2 Hz, 2H), 7.50–7.42 (m, 4H), 7.27 (d, J = 7.6 Hz, 2H), 3.69 (d,
J = 12.3 Hz, 2H), 3.22 (t, J = 8.9 Hz, 2H), 3.05–2.88 (m, 2H), 2.78–
2.62 (m, 2H), 2.52 (dd, J = 19.1, 9.6 Hz, 1H), 2.37 (td, J = 9.5,
6.6 Hz, 1H), 2.24–2.08 (m, 2H), 1.93–1.60 (m, 4H), 1.38 (s, 9H)
ppm. 13C NMR (100 MHz, CDCl3): d = 174.2, 135.0, 133.2, 131.4,
128.4, 128.3, 127.7, 127.5, 125.8, 125.5, 68.8, 55.9, 54.82, 54.7,
54.7, 50.2, 30.6, 29.7, 28.9, 24.3 ppm. ESI-MS+ m/z calcd. For
PPh3)2 (0.46 g, 0.70 mmol) in ether (80 mL) was added dropwise
methyl magnesiumbromide (3.0 M in ether, 15 mL) at 0 °C. The
reaction mixture was stirred at room temperature for 24 h. The
reaction was quenched by the addition of water (10 mL) slowly
at 0 °C and then diluted with 5% aqueous HCl (20 mL). The aqueous
layer was extracted with ether (3 ꢂ 50 mL). The combined organic
layer was washed with NaHCO3 (20 mL), dried over anhydrous and
concentrated to afford 3 as a light yellow solid (2.14 g, 91.2% yield),
C
33H38N3O 492.3015 [M+H]+; found 492.3025. [
0.5, CH2Cl2).
a
]
D
25 = ꢁ222.8 (c
mp = 66–68 °C [lit.12
:
68–72 °C]. 1H NMR (400 MHz, CDCl3):
d = 7.87 (d, J = 8.5 Hz, 2H), 7.85 (d, J = 8.4 Hz, 2H), 7.36 (d,
J = 8.3 Hz, 2H), 7.35–7.33 (m, 2H), 7.19–7.16 (m, 2H), 7.05 (d,
J = 8.4, 2H), 2.02 (s, 6H) ppm. 13C NMR (100 MHz, CDCl3):
d = 135.1, 134.3, 132.8, 132.2, 128.8, 127.9, 127.4, 126.1, 125.6,
4.2.3. (S)-1-(2-((R)-3H-Dinaphtho[2,1-c:10,20-e]azepin-4(5H)-yl)
ethyl)-N-cyclohexylpyrrolidine-2-carboxamide L3
Light yellow solid (0.57 g, 54.8% yield), mp = 82–84 °C. 1H NMR
(400 MHz, CDCl3): d = 7.99–7.88 (m, 4H), 7.53 (d, J = 8.2 Hz, 2H),
7.47 (dd, J = 7.6, 6.5 Hz, 4H), 7.28 (dd, J = 7.1, 1.5 Hz, 2H), 3.83–
3.73 (m, 1H), 3.70 (d, J = 12.3 Hz, 2H), 3.29–3.19 (m, 3H), 3.11
(dd, J = 10.1, 4.5 Hz, 1H), 2.94 (dt, J = 10.1, 7.2 Hz, 1H), 2.78–2.66
(m, 2H), 2.51 (dd, J = 14.6, 4.7 Hz, 1H), 2.44–2.34 (m, 1H), 2.28–
2.12 (m, 2H), 2.01–1.92 (m, 1H), 1.87 (ddd, J = 12.6, 7.9, 3.5 Hz,
2H), 1.81–1.59 (m, 5H), 1.48–1.32 (m, 2H), 1.22–1.05 (m, 3H)
ppm. 13C NMR (100 MHz, CDCl3): d = 174.0, 135.0, 133.2, 133.0,
131.4, 128.4, 128.3, 127.7, 127.4, 125.9, 125.6, 68.0, 55.8, 54.8,
54.4, 47.5, 33.4, 33.1, 30.7, 25.6, 25.0, 24.9, 24.3 ppm. ESI-MS+ m/
124.9, 20.0 ppm. [
a]
25 = ꢁ40.5 (c 1, CH2Cl2).
D
4.1.4. General synthetic procedures for (R)-2,20-dibromomethyl-
1,10-binaphthyl 4
To
a
solution of (R)-2,20-dimethyl-1,10-binaphthyl (2.8 g,
10.0 mmol) in cyclohexane (60 mL) was added N-bromosuccin-
imide (3.56 g, 20.0 mmol) and benzoyl peroxide (0.24 g, 1.0 mmol).
The reaction mixture was heated at reflux and irradiated under a
250 W infrared lamp for 8 h. The reaction mixture was cooled to
room temperature and filtered. The filtrate was concentrated
under reduced pressure. After removal of the solvent, the residue
was recrystallized from EtOAc to afford 4 as a white solid (2.64 g,
z
calcd. for C
35H40N3O 518.3171 [M+H]+; found 518.3168.
[a
]
25 = ꢁ229.4 (c 0.5, CH2Cl2).
D
60.0% yield), mp = 184–186 °C [lit.21
:
185–187 °C]. 1H NMR
4.2.4. (S)-1-(2-((R)-3H-Dinaphtho[2,1-c:10,20-e]azepin-4(5H)-yl)
ethyl)-N-phenylpyrrolidine-2-carboxamide L4
(400 MHz, CDCl3): d = 8.02 (d, J = 8.0 Hz, 2H), 7.92 (d, J = 8.0 Hz,
2H), 7.75 (d, J = 8.0 Hz, 2H), 7.46–7.44 (m, 2H), 7.25–7.23 (m,
2H), 7.06 (d, J = 8.0 Hz, 2H), 4.26 (s, 4H) ppm. 13C NMR (100 MHz,
CDCl3): d = 134.2, 134.1, 133.3, 132.5, 129.4, 128.0, 127.8, 127.6,
Light yellow solid (0.62 g, 60.3% yield), mp = 165–168 °C. 1H
NMR (400 MHz, CDCl3): d = 10.01 (s, 1H), 7.92 (d, J = 8.1 Hz, 2H),
7.79 (d, J = 8.2 Hz, 2H), 7.63 (d, J = 7.9 Hz, 2H), 7.44 (dd, J = 14.3,
7.5 Hz, 4H), 7.30 (t, J = 7.9 Hz, 3H), 7.24 (dd, J = 8.4, 1.8 Hz, 3H),
7.15 (t, J = 7.4 Hz, 1H), 4.12 (q, J = 7.1 Hz, 2H), 3.70 (d, J = 12.3 Hz,
2H), 3.33–3.19 (m, 3H), 3.04–2.90 (m, 1H), 2.48 (dt, J = 14.3,
7.4 Hz, 2H), 2.33–2.18 (m, 1H), 2.14–2.06 (m, 1H), 1.93–1.68 (m,
3H) ppm. 13C NMR (100 MHz, CDCl3): d = 178.0, 138.1, 135.0,
133.1, 131.3, 129.0, 128.3, 128.2, 127.8, 127.4, 125.8, 125.6,
124.0, 119.9, 68.4, 60.4, 55.8, 54.8, 54.1, 30.7, 29.6, 24.6, 21.1,
14.2 ppm. ESI-MS+ m/z calcd. for C35H34N3O 512.2702 [M+H]+;
126.8, 32.6 ppm. [
a]
25 = ꢁ89.3 (c 1, CH2Cl2).
D
4.2. General synthetic procedures for ligand L
A solution of 2 (2.0 mmol), 4 (0.97 g, 2.2 mmol), and triethy-
lamine (0.44 g, 4.4 mmol) in anhydrous CH2Cl2 (30 ml) was heated
at reflux for 24 h under Ar. The reaction was cooled to room tem-
perature and quenched by the addition of distilled water (15 ml),
and the aqueous layer was extracted with CH2Cl2. The combined
organic phase was washed with brine, and dried over Na2SO4. After
removal of the solvent under reduced pressure, the residue was
purified by column chromatography using silica gel (Hexane/
EtOAc = 3/1, v/v) to give product L.
found 512.2715. [
a]
25 = ꢁ297.4 (c 0.5, CH2Cl2).
D
4.2.5. (S)-1-(2-((R)-3H-Dinaphtho[2,1-c:10,20-e]azepin-4(5H)-yl)
ethyl)-N-(naphthalen-1-yl)pyrrolidine-2-carboxamide L5
Light yellow solid (0.65 g, 55.2% yield), mp = 200–202 °C. 1H
NMR (400 MHz, CDCl3): d = 10.47 (s, 1H), 8.17–8.10 (m, 1H),
7.95–7.90 (m, 2H), 7.89–7.84 (m, 2H), 7.84–7.80 (m, 1H), 7.74–
7.68 (m, 1H), 7.57–7.50 (m, 1H), 7.49–7.42 (m, 4H), 7.42–7.35
(m, 3H), 7.25–7.16 (m, 3H), 7.00 (s, 1H), 3.65 (s, 2H), 3.56–3.48
(m, 1H), 3.44 (dd, J = 10.2, 4.0 Hz, 1H), 3.23–3.04 (m, 3H), 3.00–
2.88 (m, 2H), 2.70–2.58 (m, 2H), 2.33 (ddd, J = 18.9, 12.9, 9.6 Hz,
4.2.1. (S)-1-(2-((R)-3H-Dinaphtho[2,1-c:10,20-e]azepin-4(5H)-yl)
ethyl)-N-butylpyrrolidine-2-carboxamide L1
Yellow colloidal solid (0.49 g, 50.3% yield), mp = 56–60 °C. 1H
NMR (400 MHz, CDCl3): d = 7.95 (d, J = 8.4 Hz, 4H), 7.51 (d,
J = 8.2 Hz, 2H), 7.47 (dd, J = 7.4, 5.8 Hz, 4H), 7.28 (d, J = 7.8 Hz,
2H), 3.68 (d, J = 12.3 Hz, 2H), 3.39 (td, J = 13.9, 7.1 Hz, 1H), 3.28–
3.18 (m, 4H), 3.15 (dd, J = 10.0, 4.2 Hz, 1H), 2.98–2.85 (m, 1H),
2.81–2.66 (m, 2H), 2.52–2.34 (m, 2H), 2.29–2.10 (m, 2H), 1.98–
1.87 (m, 1H), 1.84–1.66 (m, 2H), 1.52–1.42 (m, 2H), 1.34 (dq,
J = 14.1, 7.0 Hz, 2H), 0.88 (t, J = 7.3 Hz, 3H) ppm. 13C NMR
(100 MHz, CDCl3): d = 175.1, 135.1, 135.0, 133.3, 133.2, 133.1,
132.6, 131.4, 128.6, 128.4, 128.3, 128.3, 127.6, 127.5, 127.4,
126.0, 125.9, 125.7, 125.6, 68.0, 58.4, 56.5, 55.9, 55.1, 54.7, 54.4,
38.8, 31.9, 30.7, 29.7, 29.4, 24.5, 22.7, 20.2, 14.1, 13.8 ppm. ESI-
MS+ m/z calcd. for C33H38N3O 492.3015 [M+H]+; found 492.3014.
1H), 2.22–2.12 (m, 1H), 1.99–1.90 (m, 2H) ppm.13
C NMR
(100 MHz, CDCl3): d = 173.7, 134.9, 134.0, 133.1, 132.7, 131.3,
128.5, 128.3, 127.7, 127.4, 126.4, 125.9, 125.8, 125.6, 125.5,
124.6, 120.5, 118.5, 68.9, 55.8, 55.0, 54.7, 54.3, 31.0, 24.9 ppm.
ESI-MS+ m/z calcd. for
C
39H36N3O 562.2858 [M+H]+; found
562.2819. [
a
]
D
31 = +239.0 (c 0.5, CH2Cl2).
4.2.6. (R)-4-(2-(Pyrrolidin-1-yl)ethyl)-4,5-dihydro-3H-dinaphtho
[2,1-c:10,20-e]azepine L6
To a solution of pyrrolidine (15.0 mmol) in CH3CN (60 mL) was
added K2CO3 (3.10 g, 22.5 mmol) and N-Cbz-2-bromoethylamine
(3.87 g, 15.0 mmol) under stirring and kept at 80 °C, and monitored
by TLC (Hexane/EtOAc = 2/1, v/v), after which K2CO3 was removed
by filtration. The filtrate was concentrated to give a light brown oil.
The oil was dissolved in ethyl acetate (150 mL) and the solution
was washed with water (2 ꢂ 50 mL). The organic phase was dried
[a
]
25 = ꢁ248.0 (c 0.5, CH2Cl2).
D
4.2.2. (S)-1-(2-((R)-3H-Dinaphtho[2,1-c:10,20-e]azepin-4(5H)-yl)
ethyl)-N-(tert-butyl)pyrrolidine-2-carboxamide L2
Light yellow solid (0.53 g, 53.7% yield), mp = 168–170 °C. 1H
NMR (400 MHz, CDCl3): d = 7.95 (d, J = 8.4 Hz, 4H), 7.53 (d,